Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.

Issa-Nummer Y; Darb-Esfahani S; Loibl S; Kunz G; Nekljudova V; Schrader I; Sinn BV; Ulmer HU; Kronenwett R; Just M

doi:10.1371/journal.pone.0079775

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.

Identifier:nobleid.org/w1/20260526/5ACCFBAE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5ACCFBAE.svg?ark=w1%2F20260526%2F5ACCFBAE)](https://nobleid.org/work/w1/20260526/5ACCFBAE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.

Identifier:nobleid.org/w1/20260526/5ACCFBAE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5ACCFBAE.svg?ark=w1%2F20260526%2F5ACCFBAE)](https://nobleid.org/work/w1/20260526/5ACCFBAE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work